
GC31764
Gefarnate
Also known as [(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate
Gefarnate is a drug used for the treatment of gastritis and gastric ulcer, and has been proposed for use in the treatment of dry eye syndrome
ChemicalCAS51-77-4MW400.64FormulaC27H44O2
- CAS number
- 51-77-4
- Molecular weight
- 400.64
- Formula
- C27H44O2
- Solubility
- DMSO : ≥ 100 mg/mL (249·60 mM)
- InChIKey
- ZPACYDRSPFRDHO-ROBAGEODSA-N
- Catalogue number
- GC31764
- Brand
- GLPBIO
Computed properties PubChem CID 5282182 · XLogP 9.1 · TPSA 26.3 Ų · H-bond donors 0
- XLogP
- 9.1
- TPSA
- 26.3 Ų
- H-bond donors
- 0
- H-bond acceptors
- 2
- Rotatable bonds
- 15
- Heavy atoms
- 29
SMILES CC(=CCC/C(=C/CC/C(=C/CCC(=O)OC/C=C(\C)/CCC=C(C)C)/C)/C)C
Computed descriptors from PubChem (CID 5282182), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il